Nicholson Wealth Management Group LLC grew its stake in Colgate-Palmolive (NYSE:CL – Free Report) by 141.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 15,906 shares of the company’s stock after buying an additional 9,311 shares during the quarter. Nicholson Wealth Management Group LLC’s holdings in Colgate-Palmolive were worth $1,446,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Swedbank AB lifted its position in shares of Colgate-Palmolive by 1.4% during the 3rd quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock worth $306,246,000 after purchasing an additional 40,324 shares during the last quarter. Sequoia Financial Advisors LLC lifted its position in shares of Colgate-Palmolive by 0.6% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after purchasing an additional 113 shares during the last quarter. Eastern Bank acquired a new position in shares of Colgate-Palmolive during the 3rd quarter worth about $969,000. Private Advisor Group LLC lifted its position in shares of Colgate-Palmolive by 5.4% during the 3rd quarter. Private Advisor Group LLC now owns 68,952 shares of the company’s stock worth $7,158,000 after purchasing an additional 3,543 shares during the last quarter. Finally, Lecap Asset Management Ltd. acquired a new position in shares of Colgate-Palmolive during the 3rd quarter worth about $1,134,000. Institutional investors and hedge funds own 80.41% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities analysts recently weighed in on CL shares. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. TD Cowen cut their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Morgan Stanley lowered their price target on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. Piper Sandler lowered their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. Finally, Stifel Nicolaus lowered their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research note on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $101.16.
Colgate-Palmolive Trading Up 0.4 %
CL stock opened at $87.80 on Friday. Colgate-Palmolive has a 1-year low of $84.45 and a 1-year high of $109.30. The firm has a market cap of $71.25 billion, a P/E ratio of 24.94, a P/E/G ratio of 4.12 and a beta of 0.44. The business’s 50 day moving average is $89.02 and its 200-day moving average is $95.99. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the company posted $0.87 EPS. Equities analysts anticipate that Colgate-Palmolive will post 3.76 earnings per share for the current fiscal year.
Colgate-Palmolive Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.28%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 56.82%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- The Risks of Owning Bonds
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.